Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sara R Privatt"'
Autor:
Sydney J Bennett, Dicle Yalcin, Sara R Privatt, Owen Ngalamika, Salum J Lidenge, John T West, Charles Wood
Publikováno v:
PLoS Pathogens, Vol 20, Iss 2, p e1012023 (2024)
Protein-level immunodominance patterns against Kaposi sarcoma-associated herpesvirus (KSHV), the aetiologic agent of Kaposi sarcoma (KS), have been revealed from serological probing of whole protein arrays, however, the epitopes that underlie these p
Externí odkaz:
https://doaj.org/article/56f0a014e5364b0e998bfcf50809610e
Autor:
Sydney J Bennett, Dicle Yalcin, Sara R Privatt, Owen Ngalamika, Salum J Lidenge, John T West, Charles Wood
Publikováno v:
PLoS Pathogens, Vol 18, Iss 12, p e1011033 (2022)
The humoral antibody response against Kaposi sarcoma-associated herpesvirus (KSHV) in infected individuals has been characterized demonstrating the latency-associated nuclear antigen (LANA) as the most antigenic KSHV protein. Despite the antigenicity
Externí odkaz:
https://doaj.org/article/e033fd99c467476fa898ab13c2276347
Autor:
For Yue Tso, Salum J Lidenge, Lisa K Poppe, Phoebe B Peña, Sara R Privatt, Sydney J Bennett, John R Ngowi, Julius Mwaiselage, Michael Belshan, Jacob A Siedlik, Morgan A Raine, Juan B Ochoa, Julia Garcia-Diaz, Bobby Nossaman, Lyndsey Buckner, W Mark Roberts, Matthew J Dean, Augusto C Ochoa, John T West, Charles Wood
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247640 (2021)
BackgroundNeutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune responses, it is possible that an
Externí odkaz:
https://doaj.org/article/18b2d9c0886e4f2fbd6c07e0df919bed
Autor:
Salum J Lidenge, Andrew V Kossenkov, For Yue Tso, Jayamanna Wickramasinghe, Sara R Privatt, Owen Ngalamika, John R Ngowi, Julius Mwaiselage, Paul M Lieberman, John T West, Charles Wood
Publikováno v:
PLoS Pathogens, Vol 16, Iss 7, p e1008681 (2020)
In sub-Saharan Africa, endemic Kaposi's sarcoma (EnKS) is still prevalent despite high incidence of epidemic Kaposi's sarcoma (EpKS) resulting from the on-going HIV-1 epidemic. While KSHV is clearly the etiologic agent of KS, the mechanisms underlyin
Externí odkaz:
https://doaj.org/article/85190871773e4232b6735d2d920496ed
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2171
HIV-associated epidemic Kaposi sarcoma (EpKS) remains one of the most prevalent cancers in sub-Saharan Africa despite the widespread uptake of anti-retroviral therapy and HIV-1 suppression. In an effort to define potential therapeutic targets against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1947f716d849350212957f0fa4329d03
https://doi.org/10.3390/cancers15072171
https://doi.org/10.3390/cancers15072171
Autor:
For Yue Tso, Salum J. Lidenge, Julius Mwaiselage, Andrew V. Kossenkov, Owen Ngalamika, John R. Ngowi, Jayamanna Wickramasinghe, Paul M. Lieberman, Sara R. Privatt, John T. West, Charles E. Wood
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 16, Iss 7, p e1008681 (2020)
PLoS Pathogens, Vol 16, Iss 7, p e1008681 (2020)
In sub-Saharan Africa, endemic Kaposi’s sarcoma (EnKS) is still prevalent despite high incidence of epidemic Kaposi’s sarcoma (EpKS) resulting from the on-going HIV-1 epidemic. While KSHV is clearly the etiologic agent of KS, the mechanisms under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae6f63bf738d383ab46e0000bec7b1c
http://europepmc.org/articles/PMC7406108
http://europepmc.org/articles/PMC7406108
Publikováno v:
Vaccine
Vaccination offers the most cost-effective approach to limiting the adverse impact of infectious and neoplastic diseases that reduce the quality of life in sub-Saharan Africa (SSA). However, it is unclear what vaccine vectors would be most readily im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1761e16e7e3a204a72404c03d850a807
https://pubmed.ncbi.nlm.nih.gov/31378535
https://pubmed.ncbi.nlm.nih.gov/31378535
Autor:
Lyndsey R. Buckner, Matthew J. Dean, Augusto C. Ochoa, Morgan A. Raine, Juan B. Ochoa, John T. West, Bobby D. Nossaman, Phoebe B. Peña, Julia Garcia-Diaz, Lisa K. Poppe, For Yue Tso, Julius Mwaiselage, Jacob A. Siedlik, Charles E. Wood, Salum J. Lidenge, John R. Ngowi, Michael Belshan, Sara R. Privatt, Sydney J. Bennett, W. Mark Roberts
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247640 (2021)
PLoS ONE
PLoS ONE
Background Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune responses, it is possible that a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f39c50f5734c4b3933b331eb2897b9
https://doi.org/10.1371/journal.pone.0247640
https://doi.org/10.1371/journal.pone.0247640
Autor:
Sara R. Privatt, Camila Pereira Braga, Alicia Johnson, Salum J. Lidenge, Luke Berry, John R. Ngowi, Owen Ngalamika, Andrew G. Chapple, Julius Mwaiselage, Charles Wood, John T. West, Jiri Adamec
Publikováno v:
Cancer & Metabolism, Vol 11, Iss 1, Pp 1-15 (2023)
Abstract Background Kaposi sarcoma (KS) is a neoplastic disease etiologically associated with infection by the Kaposi sarcoma-associated herpesvirus (KSHV). KS manifests primarily as cutaneous lesions in individuals due to either age (classical KS),
Externí odkaz:
https://doaj.org/article/c3765622c801498284238b6b99eecbfe